Article · 2015
Editor
Hitt J Sharma
Serum Institute of India Ltd
About
As published by the journal they serve.
Dr. Hitt J. Sharma is working at Serum Institute of India Ltd, Pune (India), a leading Institute and the largest manufacturer of vaccines in India, exporting vaccines through WHO, UNICEF, PAHO to more than 140 countries, worldwide. He is an expert on vaccine clinical trials and is responsible for organizing and monitoring clinical trials. The main emphasis lies upon logistic support to clinical trials, pharmaco-vigilance, preparation of clinical documents and study reports for submission to National regulatory Authority, India and to W.H.O. Dr. Sharma has successfully undertaken numerous vaccine research projects including projects on anti-rabies vaccines, MMR, DPT, BCG, Hepatitis-B, Haemophilus influenzae type b & various pediatric combination vaccines. His research also includes a herbal drug in BPH patients (Pygeum africanum) and a percutaneous BCG vaccine (Onco-BCG) in transitional cell carcinoma of urinary bladder. He has to his credit one of the largest clinical trial with MMR Vaccine wherein he organized and monitored the study on 450,000 children in collaboration with Ministry of Health and Population, Cairo, Egypt. He has many publications on vaccines in National and International journals and is a member of various scientific societies in India.
Research interests
Journals they serve
The seats these journals name them in.
- Pharmaceutical Regulatory Affairs: Open AccessEditor
- Pharmaceutical Regulatory Affairs: Open AccessEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2015
Regulations in Development of Biosimilars
Article · 2014
Regulatory Practice in Pharmaceutical Industry
Article · 2012
Regulatory Inspection of Clinical Trials
Article · 2012
Clinical Trials Regulations in India
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
